Model
Edge
Nabriva Therapeutics
0001693064
Filing Type
4
Filing Date
11/7/2022
Updated
11/8/22, 10:26 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership